TIIC

Xiangju Zeng1, Zhijie Lu2, Caixia Dai2

  • 1Department of Outpatient, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.

Discover oncology
|August 26, 2024
PubMed
概括

一个新的RNA签名得分预测了膀癌患者的生存率和免疫治疗反应. 该工具有助于评估膀癌的预后和治疗有效性.

相关概念视频